Rubius Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RUBY and other ETFs, options, and stocks.

About RUBY

Rubius Therapeutics, Inc. engages in the development of red-cell therapeutic medicines for cancer, autoimmune diseases, hemophilia, and infectious and metabolic diseases. The company was founded by Avak Kahvejian, Jordi Mata-Fink, and Noubar Afeyan on April 26, 2013 and is headquartered in Cambridge, MA. 

CEO
Pablo J. Cagnoni
CEOPablo J. Cagnoni
Employees
269
Employees269
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2013
Founded2013
Employees
269
Employees269

RUBY Key Statistics

Market cap
36.84M
Market cap36.84M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
3.55M
Average volume3.55M
High today
$0.45
High today$0.45
Low today
$0.3904
Low today$0.3904
Open price
$0.4333
Open price$0.4333
Volume
869.32K
Volume869.32K
52 Week high
$18.39
52 Week high$18.39
52 Week low
$0.3904
52 Week low$0.3904

RUBY Earnings

-$0.61
-$0.41
-$0.20
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 7, Pre-Market
ActualExpected Nov 7, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.